{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T03:56:09Z","timestamp":1772596569000,"version":"3.50.1"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T00:00:00Z","timestamp":1758412800000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Novartis and GSK R&D","award":["GSKNVS1\/202101\/001"],"award-info":[{"award-number":["GSKNVS1\/202101\/001"]}]},{"name":"Grants Innovation and Product Development unit of the South African Medical Research Council"},{"name":"Novartis and GSK R&D","award":["GSKNVS1\/202101\/001"],"award-info":[{"award-number":["GSKNVS1\/202101\/001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Currently, many of the world\u2019s most culturally and genetically diverse populations, located in Africa, risk exclusion from advancements in pharmacogenomics (PGx) and personalized medicine. Optimizing treatment outcomes for these populations is crucial, particularly for widespread diseases such as tuberculosis (TB). Reducing adverse drug reactions is essential for improving treatment adherence and overall outcomes. However, investigating the PGx landscape in African populations is challenging due to the lack of genotype and phenotype data, as well as limited computational tools and resources tailored to their genetic diversity. This study assessed various bioinformatic methodologies to characterize variations in the absorption, distribution, metabolism, and excretion (ADME) of anti-TB drugs in a large African cohort (&amp;gt;21 populations from public and in-house datasets). Special focus was placed on the Khoe-San, one of Africa\u2019s most genetically diverse groups, and the South African Coloured (SAC) community, whose richly diverse genetic background arises from recent admixture. We developed a graphic resource to support the investigation of anti-TB drug PGx in Africa. African-specific genomic studies addressing major health challenges on the continent are critical for informing the development of relevant genotyping and reference panels, enabling more cost-efficient personalized care in the region. This study offers a comprehensive assessment of the TB PGx landscape in Africa and highlights the potential of computational methods to promote the inclusion of genomically diverse African populations in PGx research.<\/jats:p>","DOI":"10.1093\/bib\/bbaf484","type":"journal-article","created":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T13:49:11Z","timestamp":1758462551000},"source":"Crossref","is-referenced-by-count":1,"title":["Characterization of the complex TB pharmacogenomic landscape in Africa using bioinformatic tools"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9477-6998","authenticated-orcid":false,"given":"Carola","family":"Oelofse","sequence":"first","affiliation":[{"name":"South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anwani","family":"Siwada","sequence":"additional","affiliation":[{"name":"South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaleila","family":"Flisher","sequence":"additional","affiliation":[{"name":"South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlo","family":"M\u00f6ller","sequence":"additional","affiliation":[{"name":"South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town ,","place":["South Africa"]},{"name":"Centre for Bioinformatics and Computational Biology, Stellenbosch University , Stellenbosch ,","place":["South Africa"]},{"name":"National Institute for Theoretical and Computational Sciences (NITheCS) ,","place":["South Africa"]},{"name":"Genomics for Health in Africa (GHA), Africa-Europe Cluster of Research Excellence (CoRE) ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2358-0135","authenticated-orcid":false,"given":"Caitlin","family":"Uren","sequence":"additional","affiliation":[{"name":"South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town ,","place":["South Africa"]},{"name":"Centre for Bioinformatics and Computational Biology, Stellenbosch University , Stellenbosch ,","place":["South Africa"]},{"name":"National Institute for Theoretical and Computational Sciences (NITheCS) ,","place":["South Africa"]},{"name":"Genomics for Health in Africa (GHA), Africa-Europe Cluster of Research Excellence (CoRE) ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,21]]},"reference":[{"key":"2025092109490649900_ref1","doi-asserted-by":"publisher","first-page":"090","DOI":"10.1055\/s-0042-1743567","article-title":"Genetic variants and drug efficacy in tuberculosis: a step toward personalized therapy","volume":"09","author":"Khan","year":"2022","journal-title":"Glob Med Genet"},{"key":"2025092109490649900_ref2","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1164\/rccm.202103-0564OC","article-title":"A rapid pharmacogenomic assay to detect nat2 polymorphisms and guide isoniazid dosing for tuberculosis treatment","volume":"204","author":"Verma","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2025092109490649900_ref3","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1111\/bcp.15329","article-title":"Pharmacogenomics: relevance and opportunities for clinical pharmacology","volume":"88","author":"Turner","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"2025092109490649900_ref4","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1093\/cid\/ciz1212","article-title":"Cost-effectiveness of a pharmacogenomic test for stratified isoniazid dosing in treatment of active tuberculosis","volume":"71","author":"Rens","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025092109490649900_ref5","volume-title":"Global Tuberculosis Report 2022"},{"key":"2025092109490649900_ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182010678","article-title":"Tuberculosis treatment outcome and predictors in africa: a systematic review and meta-analysis","volume":"18","author":"Teferi","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2025092109490649900_ref7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","article-title":"Antituberculosis drug-induced hepatotoxicity: concise up-to-date review","volume":"23","author":"Tostmann","year":"2008","journal-title":"Journal of Gastroenterology and Hepatology (Australia)"},{"key":"2025092109490649900_ref8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1164\/ajrccm.156.3.9609132","article-title":"The early bactericidal activity of isoniazid related to its dose size in pulmonary","volume":"156","author":"Donald","year":"1997","journal-title":"Tuberculosis."},{"key":"2025092109490649900_ref9","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1128\/AAC.00353-10","article-title":"Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations","volume":"54","author":"Weiner","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2025092109490649900_ref10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2147\/pgpm.s363058","article-title":"Effect of genetic variations in drug-metabolizing enzymes and drug transporters on the pharmacokinetics of Rifamycins: a systematic review","volume":"Volume 15","author":"Sileshi","year":"2022","journal-title":"Pharmgenomics Pers Med"},{"key":"2025092109490649900_ref11","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/cid\/ciae119","article-title":"Pharmacokinetic-pharmacodynamic evidence from a phase 3 trial to support flat-dosing of rifampicin for tuberculosis","volume":"78","author":"Ngo","journal-title":"Clinical Infectious Diseases"},{"key":"2025092109490649900_ref12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2125.2011.03940.x","article-title":"Variability in the population pharmacokinetics of isoniazid in south African tuberculosis patients","volume":"72","author":"Wilkins","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"2025092109490649900_ref13","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1086\/599040","article-title":"Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana","volume":"48","author":"Chideya","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2025092109490649900_ref14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fgene.2021.652704","article-title":"Functional characterization of the effects of N-acetyltransferase 2 alleles on N-acetylation of eight drugs and worldwide distribution of substrate-specific diversity","volume":"12","author":"Fukunaga","year":"2021","journal-title":"Front Genet"},{"key":"2025092109490649900_ref15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/infdis\/jiac024","article-title":"Pharmacogenetics of between-individual variability in plasma clearance of Bedaquiline and clofazimine in South Africa","volume":"226","author":"Haas","year":"2022","journal-title":"J Infect Dis"},{"key":"2025092109490649900_ref16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2217\/pgs-2017-0144","article-title":"Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in south African patients with tuberculosis","volume":"19","author":"Naidoo","year":"2018","journal-title":"Pharmacogenomics."},{"key":"2025092109490649900_ref17","doi-asserted-by":"publisher","first-page":"e027940","DOI":"10.1136\/bmjopen-2018-027940","article-title":"Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis","volume":"9","author":"Yang","year":"2019","journal-title":"BMJ Open"},{"key":"2025092109490649900_ref18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics9060307","article-title":"Influence of single nucleotide polymorphisms on rifampin pharmacokinetics in tuberculosis patients","volume":"9","author":"Thomas","year":"2020","journal-title":"Antibiotics."},{"key":"2025092109490649900_ref19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13643-017-0533-4","article-title":"Influence of genetic variants on toxicity to anti-tubercular agents: a systematic review and meta-analysis (protocol)","volume":"6","author":"Richardson","year":"2017","journal-title":"Syst Rev"},{"key":"2025092109490649900_ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043383","article-title":"Human cytochrome P450 1, 2, 3 families as Pharmacogenes with emphases on their antimalarial and antituberculosis drugs and prevalent African alleles","volume":"24","author":"Chamboko","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025092109490649900_ref21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2217\/pgs-2017-0176","article-title":"Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics","volume":"18","author":"Allegra","year":"2017","journal-title":"Pharmacogenomics."},{"key":"2025092109490649900_ref22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.tube.2011.12.004","article-title":"Genetic variants in antioxidant pathway: risk factors for hepatotoxicity in tuberculosis patients","volume":"92","author":"Nanashima","year":"2012","journal-title":"Tuberculosis."},{"key":"2025092109490649900_ref23","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1126\/science.1172257","article-title":"The genetic structure and history of Africans and African Americans","volume":"324","author":"Tishkoff","year":"2009","journal-title":"Science (1979)"},{"key":"2025092109490649900_ref24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41576-020-00306-8","article-title":"African genetic diversity and adaptation inform a precision medicine agenda","volume":"22","author":"Pereira","year":"2021","journal-title":"Nat Rev Genet"},{"key":"2025092109490649900_ref25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13059-019-1679-2","article-title":"African evolutionary history inferred from whole genome sequence data of 44 indigenous African populations","volume":"20","author":"Fan","year":"2019","journal-title":"Genome Biol"},{"key":"2025092109490649900_ref26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fphar.2021.634016","article-title":"The extent and impact of variation in ADME genes in sub-Saharan African populations","volume":"12","author":"Rocha","year":"2021","journal-title":"Front Pharmacol"},{"key":"2025092109490649900_ref27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ajhg.2009.01.013","article-title":"Genotype-imputation accuracy across worldwide human populations","volume":"84","author":"Huang","year":"2008","journal-title":"Am J Hum Genet"},{"key":"2025092109490649900_ref28","doi-asserted-by":"publisher","article-title":"Imputation accuracy across global human populations","author":"Cahoon","DOI":"10.1101\/2023.05.22.541241"},{"key":"2025092109490649900_ref29","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/ejhg.2017.51","article-title":"Improved imputation accuracy of rare and low-frequency variants using population-specific high-coverage WGS-based imputation reference panel","volume":"25","author":"Mitt","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"2025092109490649900_ref30","volume-title":"Investigating Southern African Genetic Diversity and its Role in TB Susceptibility; Diss","author":"Uren","year":"2017"},{"key":"2025092109490649900_ref31","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1093\/molbev\/msaa140","article-title":"Khoe-san genomes reveal unique variation and confirm the deepest population divergence in homo sapiens","volume":"37","author":"Schlebusch","year":"2020","journal-title":"Mol Biol Evol"},{"key":"2025092109490649900_ref32","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1093\/hmg\/ddab020","article-title":"Inferring recombination patterns in African populations","volume":"30","author":"Van Eeden","year":"2021","journal-title":"Hum Mol Genet"},{"key":"2025092109490649900_ref33","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/gepi.22104","article-title":"A robust and powerful two-step testing procedure for local ancestry adjusted allelic association analysis in admixed populations","volume":"42","author":"Duan","year":"2018","journal-title":"Genet Epidemiol"},{"key":"2025092109490649900_ref34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fgene.2021.716558","article-title":"Local ancestry adjusted allelic association analysis robustly captures tuberculosis susceptibility loci","volume":"12","author":"Swart","year":"2021","journal-title":"Front Genet"},{"key":"2025092109490649900_ref35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/PGPM.S179742","article-title":"Diversity in precision medicine and pharmacogenetics: methodological and conceptual considerations for broadening participation","volume":"12","author":"Popejoy","year":"2019","journal-title":"Pharmgenomics Pers Med"},{"key":"2025092109490649900_ref36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev-biodatasci-122220","article-title":"Importance of diversity in precision medicine: generalizability of genetic associations across ancestry groups toward better identification of disease susceptibility variants","volume":"2023","author":"Cruz","year":"2023","journal-title":"Annual Review of Biomedical Data Science Annu Rev Biomed Data Sci"},{"key":"2025092109490649900_ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-016-3078-3","article-title":"Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity","volume":"17","author":"Petros","year":"2016","journal-title":"BMC Genomics"},{"key":"2025092109490649900_ref38","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/cpt.2749","article-title":"Characterization of CYP2D6 pharmacogenetic variation in sub-Saharan African populations","volume":"113","author":"Twesigomwe","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"2025092109490649900_ref39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"2025092109490649900_ref40","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","article-title":"Robust relationship inference in genome-wide association studies","volume":"26","author":"Manichaikul","year":"2010","journal-title":"Bioinformatics."},{"key":"2025092109490649900_ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100332","article-title":"Performance and accuracy evaluation of reference panels for genotype imputation in sub-Saharan African populations. Cell","volume":"3","author":"Sengupta","year":"2023","journal-title":"Genomics."},{"key":"2025092109490649900_ref42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-021-03205-y","article-title":"Sequencing of 53,831 diverse genomes from the NHLBI TOPMed program","volume":"590","author":"Taliun","year":"2021","journal-title":"Nature."},{"key":"2025092109490649900_ref43","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1101\/gr.094052.109","article-title":"Fast model-based estimation of ancestry in unrelated individuals","volume":"19","author":"Alexander","year":"2009","journal-title":"Genome Res"},{"key":"2025092109490649900_ref44","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s13258-015-0332-z","article-title":"Sex difference of autosomal alleles in populations of European and African descent","volume":"37","author":"Zuo","year":"2015","journal-title":"Genes Genomics"},{"key":"2025092109490649900_ref45","doi-asserted-by":"publisher","DOI":"10.3390\/genes12101580","article-title":"Evaluating the impact of sex-biased genetic admixture in the americas through the analysis of haplotype data","volume":"12","author":"Ongaro","year":"2021","journal-title":"Genes (Basel)"},{"key":"2025092109490649900_ref46","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/humu.24309","article-title":"Variant interpretation using population databases: lessons from gnomAD","volume":"43","author":"Gudmundsson","year":"2022","journal-title":"Hum Mutat"},{"key":"2025092109490649900_ref47","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1073\/pnas.1817678116","article-title":"Genomic evidence for shared common ancestry of east African hunting-gathering populations and insights into local adaptation","volume":"116","author":"Scheinfeldt","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025092109490649900_ref48","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1164\/rccm.202309-1583OC","article-title":"A nanopore sequencing-based pharmacogenomic panel to personalize tuberculosis drug dosing","volume":"209","author":"Verma","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2025092109490649900_ref49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jpm11030179","article-title":"Pharmacogenomic biomarkers in us fda-approved drug labels (2000\u20132020)","volume":"11","author":"Kim","year":"2021","journal-title":"J Pers Med."},{"key":"2025092109490649900_ref50","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0140-6736(22)01841-4","article-title":"A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study","volume":"401","author":"Swen","year":"2023","journal-title":"The Lancet"},{"key":"2025092109490649900_ref51","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14010114","article-title":"The case for pre-Emptive pharmacogenetic screening in South Africa","volume":"14","author":"Hurrell","year":"2024","journal-title":"J Pers Med"},{"key":"2025092109490649900_ref52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1146\/annurev-pharmtox-030823","article-title":"Annual review of pharmacology and toxicology addressing ancestry and sex bias in pharmacogenomics","volume":"64","author":"Corpas","year":"2023","journal-title":"The Annual Review of Pharmacology and Toxicology is"},{"key":"2025092109490649900_ref53","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1017\/gheg.2016.21","article-title":"Disease burden and the role of pharmacogenomics in African populations","volume":"2","author":"Mpye","year":"2017","journal-title":"Glob Health Epidemiol Genom"},{"key":"2025092109490649900_ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.103939","article-title":"Advancing pharmacogenetics research in Africa: the \u201cproject Africa GRADIENT\u201d initiative","volume":"29","author":"Ndong","year":"2024","journal-title":"Drug Discov Today"},{"key":"2025092109490649900_ref55","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12020263","article-title":"SWAAT bioinformatics workflow for protein structure-based annotation of ADME gene variants","volume":"12","author":"Othman","year":"2022","journal-title":"J Pers Med"},{"key":"2025092109490649900_ref56","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/cpt.1491","article-title":"The advantages and challenges of diversity in pharmacogenomics: can minority populations bring us closer to implementation?","volume":"106","author":"Zhang","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"2025092109490649900_ref57","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2174\/187569211796957575","article-title":"Pharmacogenomic research in South Africa: lessons learned and future opportunities in the rainbow","volume":"9","author":"Warnich","year":"2011","journal-title":"Nation."},{"key":"2025092109490649900_ref58","doi-asserted-by":"publisher","first-page":"2","DOI":"10.12688\/aasopenres.12965.1","article-title":"African pharmacogenomics consortium: consolidating pharmacogenomics knowledge, capacity development and translation in Africa","volume":"2","author":"Dandara","year":"2019","journal-title":"AAS Open Res"},{"key":"2025092109490649900_ref59","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00228-008-0484-8","article-title":"Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from southern Brazil","volume":"64","author":"Possuelo","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"2025092109490649900_ref60","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/tpj.2010.79","article-title":"Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype","volume":"12","author":"Gr\u00e9en","year":"2012","journal-title":"Pharmacogenomics Journal"},{"key":"2025092109490649900_ref61","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/bcp.13130","article-title":"Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients","volume":"83","author":"Gervasini","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"2025092109490649900_ref62","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1046\/j.1440-1746.2001.02585.x","article-title":"Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S -transferase M1 \u2018null\u2019 mutation","volume":"16","author":"Roy","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"2025092109490649900_ref63","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1440-1746.2010.06355.x","article-title":"Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis","volume":"26","author":"Bose","year":"2011","journal-title":"Journal of Gastroenterology and Hepatology (Australia)"},{"key":"2025092109490649900_ref64","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13059-018-1561-7","article-title":"Genetic disease risks can be misestimated across global populations 06 biological sciences 0604 genetics","volume":"19","author":"Kim","year":"2018","journal-title":"Genome Biol"},{"key":"2025092109490649900_ref65","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1128\/AAC.49.5.1733-1738.2005","article-title":"Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?","volume":"49","author":"Kinzig-Schippers","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2025092109490649900_ref66","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/humu.9438","article-title":"Sub-Saharan African coding sequence variation and haplotype diversity at the NAT2 gene","volume":"27","author":"Patin","year":"2006","journal-title":"Hum Mutat"},{"key":"2025092109490649900_ref67","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.apsb.2016.07.014","article-title":"Isoniazid metabolism and hepatotoxicity","volume":"6","author":"Wang","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"2025092109490649900_ref68","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3892\/mmr.2012.900","article-title":"SLCO1B1*15 haplotype is associated with rifampin-induced liver injury","volume":"6","author":"Li","year":"2012","journal-title":"Mol Med Rep"},{"key":"2025092109490649900_ref69","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01802-17","article-title":"Elevated plasma moxifloxacin concentrations and SLCO1B1 g.11187G&gt;a polymorphism in adults with pulmonary tuberculosis","volume":"62","author":"Weiner","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2025092109490649900_ref70","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.1128\/AAC.01833-10","article-title":"The SLCO1B1 rs4149032 polymorphism is highly prevalent in south Africans and is associated with reduced rifampin concentrations: dosing implications","volume":"55","author":"Chigutsa","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2025092109490649900_ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2022.102246","article-title":"Pharmacogenetic testing for NAT2 genotypes in a Tanzanian population across the lifespan to guide future personalized isoniazid dosing","volume":"136","author":"Masiphephethu","year":"2022","journal-title":"Tuberculosis."}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/26\/5\/bbaf484\/64333847\/bbaf484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/26\/5\/bbaf484\/64333847\/bbaf484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T13:49:12Z","timestamp":1758462552000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbaf484\/8259887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,8,31]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbaf484","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,8,31]]},"article-number":"bbaf484"}}